# Defibrotide TMA Prophylaxis Pilot Trial

> **NCT03384693** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 25 (actual)

## Conditions studied

- Thrombotic Microangiopathies

## Interventions

- **DRUG:** Defibrotide

## Key facts

- **NCT ID:** NCT03384693
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-07-31
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03384693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03384693, "Defibrotide TMA Prophylaxis Pilot Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03384693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*